statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Oncolytics Biotech to Host Conference Call to Discuss Second Quarter Financial Results and Recent Operational Highlights

Oncolytics Biotech to Host Conference Call to Discuss Second Quarter Financial Results and Recent Operational Highlights Oncolytics Biotech to Host Conference Call to Discuss Second Quarter Financial...

American Cancer Society Projects Over 2 Million New Cases in 2024: Biotech Innovations Respond

American Cancer Society Projects Over 2 Million New Cases in 2024: Biotech Innovations Respond American Cancer Society Projects Over 2 Million New Cases in 2024: Biotech Innovations Respond PR...

Oncolytics Biotech Announces Productive FDA Type C Meeting on its Metastatic Breast Cancer Program

Oncolytics Biotech Announces Productive FDA Type C Meeting on its Metastatic Breast Cancer Program Oncolytics Biotech Announces Productive FDA Type C Meeting on its Metastatic Breast Cancer Program...

Oncolytics Biotech Announces President and Chief Executive Officer Dr. Matt Coffey to Take Medical Leave of Absence

Oncolytics Biotech Announces President and Chief Executive Officer Dr. Matt Coffey to Take Medical Leave of Absence Oncolytics Biotech Announces President and Chief Executive Officer Dr. Matt Coffey...

Biotech Advances Propel Oncology Market to $564.5B Amid Youth Cancer Spike

Biotech Advances Propel Oncology Market to $564.5B Amid Youth Cancer Spike Biotech Advances Propel Oncology Market to $564.5B Amid Youth Cancer Spike PR Newswire VANCOUVER, BC, June 20, 2024 USA News...

Oncolytics Biotech Doses First Patient in Study of Pelareorep/FOLFIRINOX Combination Therapy in Pancreatic Cancer

Oncolytics Biotech Doses First Patient in Study of Pelareorep/FOLFIRINOX Combination Therapy in Pancreatic Cancer Oncolytics Biotech Doses First Patient in Study of Pelareorep/FOLFIRINOX Combination...

From Comfort to Cure: 2024 ASCO Meeting Reveals Groundbreaking Oncology Data

From Comfort to Cure: 2024 ASCO Meeting Reveals Groundbreaking Oncology Data From Comfort to Cure: 2024 ASCO Meeting Reveals Groundbreaking Oncology Data PR Newswire VANCOUVER, BC, June 19, 2024 USA...

Pancreatic Cancer on the Rise: How Biotech Firms are Developing Groundbreaking Treatments

Pancreatic Cancer on the Rise: How Biotech Firms are Developing Groundbreaking Treatments Pancreatic Cancer on the Rise: How Biotech Firms are Developing Groundbreaking Treatments PR Newswire...

Biotech Advances in 2024: Innovative Treatments Aim to Boost Pancreatic Cancer Survival Rates

Biotech Advances in 2024: Innovative Treatments Aim to Boost Pancreatic Cancer Survival Rates Biotech Advances in 2024: Innovative Treatments Aim to Boost Pancreatic Cancer Survival Rates PR Newswire...

Biotech Sector Working to Combat Rising Cases of Colorectal Cancer in Young Adults

Biotech Sector Working to Combat Rising Cases of Colorectal Cancer in Young Adults Biotech Sector Working to Combat Rising Cases of Colorectal Cancer in Young Adults PR Newswire VANCOUVER, BC, May...

Oncolytics Biotech, Inc. engages in the development of immuno-oncolytic virus for the treatment of solid tumors and hematological malignancies. It offers a non-pathogenic, properietary isolate of the reovirus that induce selective tumor lysis, and promotes an inflamed tumor phenotype through innate and adaptive immune responses. The company was founded by Matthew C. Coffey and Bradley George Thompson on April 2, 1998 and is headquartered in Calgary, Canada.

Volume	94,830.00
52-Wk High	$2.81
52-Wk Low	$0.883

ONCY Oncolytics Biotech, Inc.

About

Feed

News

Earnings

Fundamentals